THRX

Theravance’s (THRX) CEO Rick Winningham on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Rick E. Winningham Thank you, Mike and good afternoon everyone. The past few months have been very exciting and an important time at Theravance on both the program and strategic level. Strategically we’ve … moreView todays social media effects on THRXView the latest stocks trending across Twitter. Click to view dashboardSee who Theravance is hiring next, […]

Q1 2014 Theravance Inc Earnings Conference Call (THRX) Q1 2014 Results – Earnings Call Webcast

[at Seeking Alpha] – The following audio is from a conference call that will begin on May 06, 2014 at 17:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion. moreView todays social media effects on THRXView the latest stocks trending across Twitter. Click to view dashboardSee who Theravance is […]

4:33 pm Theravance misses by $0.11, misses on revs

moreView todays social media effects on THRXView the latest stocks trending across Twitter. Click to view dashboardSee who Theravance is hiring next, click here to view […]

Theravance, Inc. Announces May 15 Record Date and June 2 Share Issue Date for Separation Into Two Companies via a Stock Dividend

[Marketwired] – Theravance, Inc. has announced the record date of May 15, 2014 for the Company’s strategic separation into two independent, publicly traded companies via a stock dividend. Each Theravance stockholder of … moreView todays social media effects on THRXView the latest stocks trending across Twitter. Click to view dashboardSee who Theravance is hiring next, click here to view […]

Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia (Transcript)

[at Seeking Alpha] – Mathai Mammen Good afternoon everyone and thank you for joining us. I’m quite excited to tell you about the recent results from the Phase II study with TD-9855, a novel norepinephrine serotonin and reuptake … moreView todays social media effects on THRXView the latest stocks trending across Twitter. Click to view dashboardSee who Theravance is hiring […]

4:07 pm Theravance announces positive results from a Phase 2 study of TD-9855 in patients With fibromyalgia; 5 mg dose did not meet statistical significance for the primary endpoint

moreView todays social media effects on THRXView the latest stocks trending across Twitter. Click to view dashboardSee who Theravance is hiring next, click here to view […]